CytomX expects cash runway to at least the second half of 2028 as Varseta-M targets a first half of 2027 registrational study
CytomX Therapeutics, Inc. · PHARMACEUTICAL PREPARATIONS · Now $3.45
-8.5% in 7d after detection
Post-detection moves
1h
—
1d
-3.0%
3d
-4.8%
7d
-8.5%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS